Gilead
Investors
Investors
Innovation in every aspect of our business has enabled us to develop best-in-class therapeutics and to successfully commercialize them worldwide.


Investor Disclaimer



Webcast ImageWebcast
Gilead Sciences at Cowen and Company Healthcare Conference (Replay)
03/11/10 at 10:20 a.m. ET
Gilead Sciences at Cowen and Company Healthcare Conference
Thursday, March 11, 2010 10:20 a.m. ET  
Webcast PresentationHelp Help
Listen to the Webcast in Windows Media Player Click here for webcast
Listen to the Webcast in Real Player Click here for webcast

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.
GILD (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$47.42
Change (%) Stock is Up 0.32 (0.68%)
Volume8,309,487
Data as of 03/12/10 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Recent News

More >>
DateTitle 
03/04/10Gilead Sciences to Present at the Cowen and Company 30th Annual Health Care Conference on Thursday, March 11Printer Friendly Version
02/22/10U.S. Food and Drug Administration Approves Cayston(R) (Aztreonam for Inhalation Solution) for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas AeruginosaPrinter Friendly Version
02/17/10Gilead's Single-Tablet "Quad" Regimen for HIV Achieves a High Rate of Virologic Suppression in Phase II StudyPrinter Friendly Version

Upcoming Events

More >>
DateTitle
03/16/10
through
03/18/10
American College of Cardiology
LocationAtlanta, GA
03/23/10
Gilead Sciences at Barclays Capital Global Healthcare Conference
LocationMiami, FL

Most Viewed Links

Updated 03/14/10
1.SEC Filings
2.Annual Reports
3.Stock Quote
4.Fundamentals - Snapshot
5.Biography
* Data collected 02/17/10 - 02/24/10

Receive E-mail Alerts

E-mail Alert Icon
Sign up to receive e-mail alerts whenever Gilead Sciences posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.